Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


23.07.2018

1 Am J Surg
1 Ann Oncol
1 Ann Surg Oncol
1 BMC Cancer
1 Br J Cancer
12 Dis Colon Rectum
1 Eur J Cancer
2 Eur J Gastroenterol Hepatol
5 Eur J Surg Oncol
4 Gastroenterology
1 Gastrointest Endosc
2 Gut
2 Int J Colorectal Dis
3 Int J Oncol
2 N Engl J Med
9 Oncol Rep
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. PANDIT V, Khan M, Martinez C, Jehan F, et al
    A modified frailty index predicts adverse outcomes among patients with colon cancer undergoing surgical intervention.
    Am J Surg. 2018 Jul 9. pii: S0002-9610(18)30413.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. VAN CUTSEM E, Yoshino T, Lenz HJ, Lonardi S, et al
    Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study.
    Ann Oncol. 2018 Jul 13. pii: 5053583. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  3. MARTIN L, Hopkins J, Malietzis G, Jenkins JT, et al
    Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Ann Surg Oncol. 2018 Jul 13. pii: 10.1245/s10434-018-6652.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. LEERMAKERS L, Doking S, Thewes B, Braamse AMJ, et al
    Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors.
    BMC Cancer. 2018;18:748.
    PubMed     Text format     Abstract available


    Br J Cancer

  5. PEETERS M, Price T, Taieb J, Geissler M, et al
    Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK
    Br J Cancer. 2018 Jul 17. pii: 10.1038/s41416-018-0165.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  6. WRENN SM, Cepeda-Benito A, Ramos-Valadez DI, Cataldo PA, et al
    Patient Perceptions and Quality of Life After Colon and Rectal Surgery: What Do Patients Really Want?
    Dis Colon Rectum. 2018;61:971-978.
    PubMed     Text format     Abstract available

  7. EMMANUEL A, Gulati S, Burt M, Hayee B, et al
    Safe and Effective Endoscopic Resection of Massive Colorectal Adenomas >/=8 cm in a Tertiary Referral Center.
    Dis Colon Rectum. 2018;61:955-963.
    PubMed     Text format     Abstract available

  8. SEGEV L, Kalady MF, Church JM
    Left-Sided Dominance of Early-Onset Colorectal Cancers: A Rationale for Screening Flexible Sigmoidoscopy in the Young.
    Dis Colon Rectum. 2018;61:897-902.
    PubMed     Text format     Abstract available

  9. COUWENBERG AM, Intven MPW, Burbach JPM, Emaus MJ, et al
    Utility Scores and Preferences for Surgical and Organ-Sparing Approaches for Treatment of Intermediate and High-Risk Rectal Cancer.
    Dis Colon Rectum. 2018;61:911-919.
    PubMed     Text format     Abstract available

  10. WATANABE J, Ishibe A, Suwa Y, Suwa H, et al
    Surgical Techniques for Identification of the Prostate Gland Using the Autonomic Nerve as a Landmark During Transanal Total Mesorectal Excision: Secure Dissection of the Male Rectourethral Muscle.
    Dis Colon Rectum. 2018;61:999-1000.
    PubMed     Text format    

  11. LIU S, Zhong GX, Zhou WX, Xue HD, et al
    Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.
    Dis Colon Rectum. 2018 Jun 25. doi: 10.1097/DCR.0000000000001135.
    PubMed     Text format     Abstract available

  12. DIAS AR, Pereira MA, de Mello ES, Nahas SC, et al
    Lymph Node Yield After Neoadjuvant Chemoradiotherapy in Rectal Cancer Specimens: A Randomized Trial Comparing Two Fixatives.
    Dis Colon Rectum. 2018;61:888-896.
    PubMed     Text format     Abstract available

  13. TAKAYANAGI D, Nemoto D, Isohata N, Endo S, et al
    Histological Comparison of Cold versus Hot Snare Resections of the Colorectal Mucosa.
    Dis Colon Rectum. 2018;61:964-970.
    PubMed     Text format     Abstract available

  14. M GEIGER T
    What Every Colorectal Surgeon Should Know About Bundled Payments for Major Bowel Procedures: Where Are We Going?
    Dis Colon Rectum. 2018;61:877-878.
    PubMed     Text format    

  15. WESTERDUIN E, Klaver CEL, van Geloven AAW, Westerterp M, et al
    Outcome After Redo Surgery for Complicated Colorectal and Coloanal Anastomosis: A Systematic Review.
    Dis Colon Rectum. 2018;61:988-998.
    PubMed     Text format     Abstract available

  16. LEEDS IL, Fang SH
    Neoadjuvant Therapy for Rectal Cancer.
    Dis Colon Rectum. 2018;61:883-886.
    PubMed     Text format    

  17. FICHERA A
    Expert Commentary on Neoadjuvant Therapy for Rectal Cancer.
    Dis Colon Rectum. 2018;61:887.
    PubMed     Text format    


    Eur J Cancer

  18. GELLI M, Huguenin JFL, de Baere T, Benhaim L, et al
    Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?
    Eur J Cancer. 2018;100:94-103.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  19. FENIG Y, Khoury M, Schmilovitz-Weiss H, Gingold-Belfer R, et al
    The outcome of transanal endoscopic microsurgery in obese patients.
    Eur J Gastroenterol Hepatol. 2018;30:113-117.
    PubMed     Text format     Abstract available

  20. LAPUMNUAYPOL K, Mahmood E, Chaiwatcharayut W, Bandres MV, et al
    Colorectal cancer in young African Americans: clinical characteristics and presentations.
    Eur J Gastroenterol Hepatol. 2018 Jul 16. doi: 10.1097/MEG.0000000000001205.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  21. HARJI DP, Vallance A, Selgimann J, Bach S, et al
    A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumour.
    Eur J Surg Oncol. 2018 Jun 23. pii: S0748-7983(18)31134.
    PubMed     Text format     Abstract available

  22. HAMMOUDI N, Eveno C, Lambert J, Maillet M, et al
    Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.
    Eur J Surg Oncol. 2018;44:799-804.
    PubMed     Text format     Abstract available

  23. WANG K, Xu D, Yan XL, Poston G, et al
    The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
    Eur J Surg Oncol. 2018;44:771-777.
    PubMed     Text format     Abstract available

  24. LO DICO R, Tijeras-Raballand A, Bonnin P, Launay JM, et al
    Hepatectomy increases metastatic graft and growth in an immunocompetent murine model of peritoneal metastases.
    Eur J Surg Oncol. 2018;44:784-791.
    PubMed     Text format     Abstract available

  25. SUGARBAKER PH
    Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment.
    Eur J Surg Oncol. 2018;44:805-809.
    PubMed     Text format     Abstract available


    Gastroenterology

  26. KANEKO M, Tanaka K, Kobayashi K
    An Unusual Lesion in the Ascending Colon.
    Gastroenterology. 2018;154:2037-2038.
    PubMed     Text format    

  27. KHOURY T, Israeli E, Yaari S
    Unfolding the Diagnosis: Rare Endoscopic Features of Unusual Cause of Colitis.
    Gastroenterology. 2018;154:e7-e8.
    PubMed     Text format    

  28. WANG L, Pei Q, Shi Y
    A Rare Submucosal Tumor of The Colon.
    Gastroenterology. 2018;154:2041-2042.
    PubMed     Text format    

  29. MISAWA M, Kudo SE, Mori Y, Cho T, et al
    Artificial Intelligence-Assisted Polyp Detection for Colonoscopy: Initial Experience.
    Gastroenterology. 2018;154:2027-2029.
    PubMed     Text format    


    Gastrointest Endosc

  30. ANDERSON JC, Robertson DJ
    Monitoring compliance with colorectal cancer screening: Do we have it covered?
    Gastrointest Endosc. 2018;88:332-334.
    PubMed     Text format    


    Gut

  31. LIBBY G, Fraser CG, Carey FA, Brewster DH, et al
    Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality.
    Gut. 2018 Jul 16. pii: gutjnl-2018-316483. doi: 10.1136/gutjnl-2018-316483.
    PubMed     Text format     Abstract available

  32. POHL H, Kaminski MF
    Mindful choice of endoscopic resection for large colorectal lesions.
    Gut. 2018;67:1374-1375.
    PubMed     Text format    


    Int J Colorectal Dis

  33. SODERBACK H, Gunnarsson U, Hellman P, Sandblom G, et al
    Incisional hernia after surgery for colorectal cancer: a population-based register study.
    Int J Colorectal Dis. 2018 Jul 17. pii: 10.1007/s00384-018-3124.
    PubMed     Text format     Abstract available

  34. CHERN YJ, Tsai WS, Hung HY, Chen JS, et al
    The dark side of laparoscopic surgery for colorectal cancer patients aged 75 years or older.
    Int J Colorectal Dis. 2018 Jul 15. pii: 10.1007/s00384-018-3130.
    PubMed     Text format     Abstract available


    Int J Oncol

  35. ZHANG H, Yang W, Yan J, Zhou K, et al
    Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
    Int J Oncol. 2018 Jul 9. doi: 10.3892/ijo.2018.4475.
    PubMed     Text format     Abstract available

  36. ZHOU ZP, Wang LP, Hong ZS, Qiu CZ, et al
    Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Int J Oncol. 2018 Jul 5. doi: 10.3892/ijo.2018.4471.
    PubMed     Text format     Abstract available

  37. LIU M, Zhao G, Zhang D, An W, et al
    Active fraction of clove induces apoptosis via PI3K/Akt/mTOR-mediated autophagy in human colorectal cancer HCT-116 cells.
    Int J Oncol. 2018 Jul 2. doi: 10.3892/ijo.2018.4465.
    PubMed     Text format     Abstract available


    N Engl J Med

  38. BAGLIONI P
    The IARC Perspective on Colorectal Cancer Screening.
    N Engl J Med. 2018;379:301.
    PubMed     Text format    


  39. The IARC Perspective on Colorectal Cancer Screening.
    N Engl J Med. 2018;379:301-302.
    PubMed     Text format    


    Oncol Rep

  40. XU Y, Liu X, Zhang H, Zhu Z, et al
    Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/beta-catenin signaling pathway in colorectal cancer.
    Oncol Rep. 2018 Jul 2. doi: 10.3892/or.2018.6539.
    PubMed     Text format     Abstract available

  41. ZHANG H, Deng Z, Zhang D, Li H, et al
    High expression of leucinerich repeatcontaining 8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.
    Oncol Rep. 2018 Jul 10. doi: 10.3892/or.2018.6556.
    PubMed     Text format     Abstract available

  42. LI Y, Xin S, Wu H, Xing C, et al
    High expression of microRNA31 and its host gene LOC554202 predict favorable outcomes in patients with colorectal cancer treated with oxaliplatin.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6571.
    PubMed     Text format     Abstract available

  43. FENG Y, Dong YW, Song YN, Xiao JH, et al
    MicroRNA449a is a potential predictor of colitisassociated colorectal cancer progression.
    Oncol Rep. 2018 Jul 12. doi: 10.3892/or.2018.6566.
    PubMed     Text format     Abstract available

  44. LI JW, Huang CZ, Li JH, Yuan JH, et al
    Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
    Oncol Rep. 2018 Jul 17. doi: 10.3892/or.2018.6581.
    PubMed     Text format     Abstract available

  45. SONG J, Wang L, Ma Q, Yang Y, et al
    Let7i5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikreinrelated peptidase 6.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6577.
    PubMed     Text format     Abstract available

  46. IIDA M, Hazama S, Tsunedomi R, Tanaka H, et al
    Overexpression of miR221 and miR222 in the cancer stroma is associated with malignant potential in colorectal cancer.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6575.
    PubMed     Text format     Abstract available

  47. JIANG T, Li H, Jiang R, Li H, et al
    Pin2/TRF1binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factorkappaB signaling pathway.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6570.
    PubMed     Text format     Abstract available

  48. YANG X, Liu W, Xu X, Zhu J, et al
    Downregulation of long noncoding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelialmesenchymal transition in colorectal cancer cells.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6573.
    PubMed     Text format     Abstract available


    PLoS One

  49. MOJTABANEZHAD SHARIATPANAHI A, Yassi M, Nouraie M, Sahebkar A, et al
    The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
    PLoS One. 2018;13:e0200735.
    PubMed     Text format     Abstract available

  50. GUERCIO BJ, Zhang S, Niedzwiecki D, Li Y, et al
    Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
    PLoS One. 2018;13:e0199244.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: